The Covid jabs target a strain called KP.2, a descendant of the highly contagious omicron subvariant JN.1 that began circulating widely in the U.S. this year.
The Food and Drug Administration approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach most Americans in the coming days as the virus surges.
Pfizer will begin shipping its new shot immediately and expects it to be available in pharmacies, hospitals and clinics across the U.S. "beginning in the coming days," the company said in a statement. Moderna expects its shot to be available in the coming days, according to a statement. The summer Covid wave may decline by the time the shots reach patients' arms and kick in an immune response against the virus, which typically takes two weeks after vaccination.
Biotechnology Biotech And Pharmaceuticals Pharmaceuticals Health Care Industry Social Issues Science Pfizer Inc Moderna Inc United States Novavax Inc Breaking News: Business Breaking News Business News
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Could OK Fall COVID Shots as Early as This WeekUpdated shots you could use this fall to shield against COVID-19 infection may receive approval this week.
Read more »
The Covid-19 Summer Wave Is So Big, the FDA Might Release New Vaccines EarlyThe latest Covid-19 surge reportedly has officials considering approval of the new strain-matched vaccine as soon as this week.
Read more »
Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatmentsPfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world.
Read more »
Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatmentsPfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world.
Read more »
Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatmentsPfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world.
Read more »
Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatmentsPfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world. Two years ago, Pfizer recorded an unprecedented $100 billion in annual sales from its COVID-19 vaccine and antiviral Paxlovid.
Read more »